Ebola Vaccine: GlaxoSmithKline Drug Could Be Ready By The End Of 2014

GlaxoSmithKline's Ebola vaccine could be ready by the end of the year and in use in West Africa by January 2015, Reuters reported. The London-based pharmaceutical giant acquired the drug when it purchased the biotech company Okairos in 2013.